Top 10 Companies in the (S)-1-Phenylethylamine (CAS 2627-86-3) Market (2026): Market Leaders Powering Global Chiral Chemistry

MARKET INSIGHTS

The Global (S)-1-Phenylethylamine (CAS 2627-86-3) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(S)-1-Phenylethylamine, identified by CAS number 2627-86-3, is a chiral primary amine and one of the most widely utilized resolving agents in asymmetric synthesis and chiral resolution processes. As the (S)-enantiomer of 1-phenylethylamine, it plays a critical role in the production of optically pure compounds, serving as a key building block in pharmaceutical synthesis, agrochemical development, and fine chemical manufacturing. Its high enantiomeric purity and reactivity make it indispensable across a range of stereoselective chemical processes.

(S)-1-Phenylethylamine (CAS 2627-86-3) Market – View in Detailed Research Report

Top 10 Companies in the (S)-1-Phenylethylamine (CAS 2627-86-3) Market (2026)

1️⃣ 1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: High-purity (S)-1-Phenylethylamine for API synthesis and chiral resolution

BASF SE is a global leader in fine chemical manufacturing, offering a wide portfolio of chiral intermediates. Its (S)-1-Phenylethylamine is produced using advanced resolution processes that ensure >99% ee, meeting stringent regulatory requirements for pharmaceutical applications.

Sustainability Initiatives:

• Investment in green chemistry and renewable feedstocks
• Reduction of solvent usage and waste generation in production
• Commitment to achieving net-zero emissions by 2050

2️⃣ 2. Lanxi Jinding Chemical Co., Ltd.

Headquarters: Lanxi, China
Key Offering: GMP-compliant (S)-1-Phenylethylamine for pharmaceutical intermediates

Lanxi Jinding specializes in chiral resolution and synthesis of fine chemicals. Their (S)-1-Phenylethylamine is manufactured via classical resolution and biocatalytic routes, ensuring high optical purity and scalability for large-volume API production.

Sustainability Initiatives:

• Implementation of energy-efficient production lines
• Use of recyclable solvents and closed-loop systems
• Participation in the China Green Chemistry Initiative

3️⃣ 3. Anhui Wotu Chemical Co., Ltd.

Headquarters: Hefei, China
Key Offering: Cost-effective (S)-1-Phenylethylamine with >99% ee for API and agrochemical synthesis

Anhui Wotu focuses on large-scale production of chiral amines, leveraging both classical resolution and enzymatic processes to meet the growing demand in the pharmaceutical and agrochemical sectors.

Sustainability Initiatives:

• Adoption of renewable energy sources in manufacturing facilities
• Optimization of raw material sourcing to reduce environmental impact
• Compliance with ISO 14001 environmental management standards

4️⃣ 4. Jiangsu Tianjiayi Chemical Co., Ltd.

Headquarters: Nanjing, China
Key Offering: High-purity (S)-1-Phenylethylamine for chiral drug development

Jiangsu Tianjiayi delivers GMP-grade (S)-1-Phenylethylamine to pharmaceutical companies, supporting the synthesis of complex chiral APIs and catalysts.

Sustainability Initiatives:

• Implementation of waste minimization programs
• Use of bio-based feedstocks where feasible
• Continuous improvement of process efficiency through Six Sigma

5️⃣ 5. Syntor Fine Chemicals Ltd.

Headquarters: London, United Kingdom
Key Offering: Pharmaceutical-grade (S)-1-Phenylethylamine for research and development

Syntor Fine Chemicals specializes in providing high-quality chiral intermediates to pharmaceutical and biotech companies, with strict control over enantiomeric excess and purity.

Sustainability Initiatives:

• Reduction of hazardous waste through process optimization
• Use of green solvents and catalysts
• Commitment to the UK Green Deal targets

6️⃣ 6. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: High-purity (S)-1-Phenylethylamine for API and fine chemical synthesis

TCI provides chiral amines to the Japanese pharmaceutical market, ensuring compliance with stringent Japanese regulatory standards and delivering consistent optical purity.

Sustainability Initiatives:

• Adoption of renewable energy in production plants
• Implementation of closed-loop water recycling systems
• Participation in Japan’s Green Industry Initiative

7️⃣ 7. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: Specialty (S)-1-Phenylethylamine for advanced research and industrial applications

Fluorochem supplies high-purity chiral amines to academia and industry, supporting innovative research in asymmetric synthesis.

Sustainability Initiatives:

• Use of biodegradable solvents in laboratory processes
• Energy-efficient manufacturing practices
• Commitment to ISO 50001 energy management

8️⃣ 8. Hubei Norna Technology Co., Ltd.

Headquarters: Wuhan, China
Key Offering: GMP-compliant (S)-1-Phenylethylamine for API synthesis

Hubei Norna focuses on producing chiral intermediates with strict quality control, catering to both domestic and international pharmaceutical clients.

Sustainability Initiatives:

• Implementation of eco-friendly production technologies
• Reduction of CO2 emissions through process optimization
• Compliance with China’s Environmental Protection Law

9️⃣ 9. Combi-Blocks Inc.

Headquarters: Newark, United States
Key Offering: Custom synthesis and supply of (S)-1-Phenylethylamine for specialized applications

Combi-Blocks offers tailored synthesis services, enabling clients to obtain (S)-1-Phenylethylamine with precise enantiomeric excess and purity levels.

Sustainability Initiatives:

• Use of green chemistry principles in custom synthesis
• Partnerships with CDMOs to reduce waste
• Commitment to carbon-neutral operations by 2030

🔟 10. Acros Organics (Thermo Fisher Scientific)

Headquarters: Wilmington, United States
Key Offering: High-purity (S)-1-Phenylethylamine for research and pharmaceutical development

Acros Organics provides a range of chiral chemicals, including (S)-1-Phenylethylamine, supporting academic research and industrial R&D with consistent quality.

Sustainability Initiatives:

• Integration of renewable energy in manufacturing
• Reduction of hazardous waste through green solvent usage
• Participation in Thermo Fisher’s sustainability program

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307761/phenylethylamine-market

Get Full Report: https://www.24chemicalresearch.com/reports/307761/phenylethylamine-market

Outlook

The market for (S)-1-Phenylethylamine is poised for robust growth driven by the expanding pipeline of chiral drugs and the increasing adoption of green chemistry in manufacturing. The shift toward single-enantiomer APIs, coupled with the rise of CDMOs and personalized medicine, will sustain demand for high-purity chiral intermediates. Geographic expansion into Asia-Pacific, especially China and India, is expected to accelerate as local pharmaceutical manufacturing ramps up and regulatory standards converge with global ICH guidelines.

Future Trends

• Advancements in biocatalytic and flow chemistry platforms to enhance scalability and reduce environmental footprint.
• Integration of AI-driven process optimization for chiral synthesis, improving yield and enantiomeric excess.
• Increased collaboration between CDMOs and fine chemical suppliers to secure supply chains for complex molecule development.
• Growing emphasis on sustainability, leading to stricter regulatory requirements for hazardous material handling and waste management.

(S)-1-Phenylethylamine (CAS 2627-86-3) Market – View in Detailed Research Report